Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: Significant factors associated with lupus nephritis

Annals of the Rheumatic Diseases

Volumn 62, Issue 6, 2003, Pages 556-560

  Alba, P ^b   Bento, L ^b   Cuadrado, M J ^a,b,d   Karim, Y ^a   Tungekar, M F ^a   Abbs, I ^c   Khamashta, M A ^b   D'Cruz, D ^b   Hughes, G R V ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Rayne Institute ^*  (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; LUPUS ANTICOAGULANT; SM ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT MONITORING; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RISK FACTORS; STATISTICS;

EID: 0037809612     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.6.556     Document Type: Article

References (38)

1. Walker WG, Solez K. Renal involvement in disorders of connective tissue. In: Earley LE, Gottschalk CW, eds. Diseases of kidneys. Boston: Little, Brown, 1979:1259-88.
2. Dang H, Harbeck RJ. The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice. Clin Immunol Immunopathol 1984;30:265-78.
3. Koffler D, Schur PH, Kunkel HG. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 1967;126:607-23.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
5. van Venrooij WJ, Charles P, Maini RN. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991;140:181-9.
6. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000;53:424-32.
7. Harris EN. Special report. The second international anticardiolipin standardization workshop. The Kingston antiphospholipid antibody study (KAPS) group. Am J Clin Pathol 1990;94:476-84.
8. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
9. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
10. Churg J, Bernstein J, Glassock RJ. Lupus nephritis. In: Renal disease: classification and atlas of glomerular diseases. 2nd ed. New York: Igaku-Shoin Medical Publishers, 1995:151-79.
11. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984;25:689-95.
12. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993;73:113-24.
13. Garcia CO, Molina JF, Gutierrez-Urena S, Scopelitis E, Wilson WA, Gharavi AE, et al. Autoantibody profile in African-American patients with lupus nephritis. Lupus 1996;5:602-5.
14. Bell DA. SLE in the elderly. Is it really SLE or Sjögren syndrome? J Rheumatol 1988;15:723-4.
15. Catoggio LJ, Skinner RP, Smith G, Maddison PJ. Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol 1984;11:175-81.
16. Kaslow RA, Masi AT. Age, sex and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 1978;21:473-9.
17. Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus. Differences related to race and age of onset. Arthritis Rheum 1982;25:55-60.
18. Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody profile in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol 1997;36:229-33.
19. Blum A, Rubinow A, Galun E. Predominance of renal involvement in male patient with systemic lupus erythematosus. Clin Exp Rheumatol 1991;9:206-7.
20. Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic PD. Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of literature. Semin Arthritis Rheum 1989;18:189-97.
21. Vargas MT, Gustilo K, D'Andrea DM, Kalluri R, Foster MH, Madaio MP.. Structural features of nephritogenic lupus autoantibodies. Methods 1997;11:62-9.
22. Bernstein KA, Di Valerio R, Lefkowith JB. Glomerular binding activity in MRL-Ipr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 1995;154:2424-33.
23. Katz JB, Limpanasithikul W, Diamond B. Mutational analysis of an autoantibody. Differential binding and pathogenicity. J Exp Med 1994;180:925-32.
24. Bell DA, Smeenk RTJ. Clinical connections: assays and assessment. Lupus 1997;6:305-6.
25. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity of systemic lupus erythematosus. Relationship berween histocompability antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum 1989;32:826-34.
26. Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982;69:835-43.
27. Reichlin M, van Venrooij W. Autoantibodies to the URNP particles; relationship to clinical diagnosis and nephritis. Clin Exp Immunol 1991;83:286-90.
28. McCarty GA, Harley JB, Reichlin M. A distinctive autoantibody profile in black female patients with lupus nephritis. Arthritis Rheum 1993;36:1560-5.
29. Joseph J, Anaya JM, Sandifer M, Scopelitis E, Wilson W, Espinoza LR. Absence of a distinctive autoantibody profile in black women with lupus nephritis. Arthritis Rheum 1994;37:1261-2.
30. Homma M, Mimori T, Yoshihiko T, Akama H, Yoshida T, Ogasawara T, et al. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol 1987;14(supp1 13):88-193.
31. Janwityanuchit S, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Anti-Sm: its predictive value in systemic lupus erythematosus. Clin Rheumatol 1993;12:350-3.
32. Lopez-Longo FJ, Gonzalez-Fernandez CM, Rodriguez Mahou M, Grau Simo R, Monteagudo Saez I, Meno Garcia AC Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies. Rev Clin Esp 1997;197:329-35.
33. Tapanes FJ, Vasquez M, Ramírez R, Matheus C, Rodriguez MA, Bianco N. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? Lupus 2000;9:437-44.
34. Frampton G, Hicks J, Cameron JS. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 1991;39:1225-31.
35. Farrugia E, Torres VE, Gostineau D, Clement J, Holley K. Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 1992;20:463-71.
36. Loizou S, Samarkos M, Norsworthy PJ, Cazabon JK, Walport MJ, Davies KA. Significance of anticardiolipin and anti-β2GPI antibodies in lupus nephritis. Rheumatology (Oxford) 2000;39:962-8.
37. Karim MY, Alba P, Tungekar MF, Abbs IC, Khamastha MA, Hughes GRV, et al. Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus 2002;11:253-6.
38. Bastian HM, Roseman JM, McGwin G, Alarcon GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002;11:152-60.